OOIR: Observatory of International Research

Papers

(The H4-Index of Clinical Chemistry is 32. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Commentary on Significance of Monoclonal Band in Cerebral Spinal Fluid	128
Commentary on a True Negative HIV Antibody Result with an Initially Incorrect Interpretation—A Diagnostic Conundrum in HIV Screening	96
Prenatal Hemoglobinopathy Evaluation	82
Foreign Objects in Stool	80
Corrigendum to: Evaluation of Radioactivity in Patient Specimens Received in the Core Laboratory at a National Cancer Institute (NCI) Designated Cancer Center	69
Multiple Copy Number Variants Detected by Noninvasive Prenatal Testing	69
How Can Digital PCR Support the Rapid Development of New Detection Tests in Future Pandemics?	66
The Impact of Climate Change on Laboratory Medicine: A Global Health Perspective	53
Low Free T4 in a 13-Year-Old Girl with Short Stature and Blurry Vision	52
Vitamin D: Analytical Advances, Clinical Impact, and Ongoing Debates on Health Perspectives	51
Applying Machine Learning to Blood Count Data Predicts Sepsis with ICU Admission	51
Small Remnants versus Large Triglyceride-Rich Lipoproteins in Risk of Atherosclerotic Cardiovascular Disease	49
A Curiosity in the Heavens: The North American Nebula (NGC 7000)	48
Clinical Chemistry’s Invited Reviewers 2021	47
Abdominal Pain and Cola-Colored Serum	46
Analytical Validation of a Novel 6-Gene Signature for Prediction of Distant Recurrence in Estrogen Receptor-Positive, HER2-Negative, Early-Stage Breast Cancer	45
Correction: Impact of Cyanokit Administration on Point-of-Care Glucose and Laboratory Test Accuracy	45
Commentary on Understanding Elevated Vitamin D Measurements to Uncover Hypercalcemia Etiology	44
The Three Phases of Medical Laboratory Testing	44
Correction to: Lower Limits for Reporting High-Sensitivity Cardiac Troponin Assays and Impact of Analytical Performance on Patient Misclassification	43
Lab Medicine in Space	43
Comprehensive Analysis of PKD1 and PKD2 by Long-Read Sequencing in Autosomal Dominant Polycystic Kidney Disease	43
B-298 Quantitation and Abundance of Xylazine and Xylazine Metabolites in Human Urine by LC-MS/MS	42
Unexpected Persistently Increased Intraoperative Parathyroid Hormone Concentrations in a Patient with Primary Hyperparathyroidism	42
Commentary on Impact of Cyanokit Administration on Point-of-Care Glucose and Laboratory Test Accuracy	41

Correction: Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring	37
Determining Cost-Optimal Next-Generation Sequencing Panels for Rare Disease and Pharmacogenomics Testing	37
Correction to: Driving Under the Influence of Cannabis: Impact of Combining Toxicology Testing with Field Sobriety Tests	36
Commentary on Severe Hypophosphatemia: The Hidden Truth	35
Analytical Quality Controls for ddPCR Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia	34
A-249 Theranostic Algorithm: sensitivity and Specificity of a Composite Index Test for Guiding Treatment in Severe COVID-19	33
A Negative Internal Standard in Urinary Metanephrines Quantification	33